NCT06019611 - Epidural Stimulation in Multiple Sclerosis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 11, 2023

Primary Completion Date

February 27, 2024

Study Completion Date

February 27, 2024

Conditions

Multiple SclerosisDemyelinating DisorderAutoimmune Diseases

Interventions

DEVICE

Percutaneous epidural stimulation

"Abbott percutaneous trial lead for epidural neurostimulation (Model 3086)~Abbott clinician programmer for epidural and dorsal root ganglion neurostimulation (Model 3874)~Ripple Neuromed Nomad Neurostimulation System"

Trial Locations (1)

55905

Mayo Clinic, Rochester